Does High-THC Cannabis Reduce Airway Collapse at Night in Sleep Apnoea?

PostedMarch 5, 2026

UpdatedMarch 5, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

High-THC cannabis is being explored for its potential to reduce airway collapse in patients with obstructive sleep apnoea (OSA) . Researchers are investigating whether high-THC cannabis for airway collapse can improve breathing stability and reduce apnoea events during sleep. Understanding the mechanism is crucial for evaluating its effectiveness and safety.

Mechanism of Action

The potential of high-THC cannabis for airway collapse lies in its ability to relax upper airway muscles and modulate neurological pathways controlling respiration.

Muscle Relaxation

THC may influence airway tone, and THC for sleep apnoea mechanism suggests reduced collapsibility of the upper airway, potentially lowering the frequency of apnoea episodes.

Sleep Architecture Improvement

By supporting airway stability, high-THC cannabis for airway collapse may promote more continuous sleep, leading to better restorative sleep phases.

Respiratory Support

Using cannabis for airway support, patients may experience improved oxygen saturation and fewer interruptions in breathing throughout the night.

Safety Considerations

While high-THC cannabis for airway collapse may offer benefits, careful dosing is essential to avoid psychoactive side effects and tolerance issues, particularly in patients with OSA and comorbidities.

Limited clinical trials support the role of high-THC cannabis for airway collapse, but early findings indicate potential for reducing nocturnal airway collapse and improving overall sleep quality in OSA patients.

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.